View source for Zotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial
Jump to navigation
Jump to search
You do not have permission to edit this page, for the following reason:
You can view and copy the source of this page.
Pages included on this page: